Associations of Total Legume, Pulse, and Soy Consumption with Incident Type 2 Diabetes: Federated Meta-Analysis of 27 Studies from Diverse World Regions.


Journal

The Journal of nutrition
ISSN: 1541-6100
Titre abrégé: J Nutr
Pays: United States
ID NLM: 0404243

Informations de publication

Date de publication:
11 05 2021
Historique:
received: 20 08 2020
revised: 02 10 2020
accepted: 21 12 2020
pubmed: 12 3 2021
medline: 2 9 2021
entrez: 11 3 2021
Statut: ppublish

Résumé

The consumption of legumes is promoted as part of a healthy diet in many countries but associations of total and types of legume consumption with type 2 diabetes (T2D) are not well established. Analyses across diverse populations are lacking despite the availability of unpublished legume consumption data in prospective cohort studies. To examine the prospective associations of total and types of legume intake with the risk of incident T2D. Meta-analyses of associations between total legume, pulse, and soy consumption and T2D were conducted using a federated approach without physical data-pooling. Prospective cohorts were included if legume exposure and T2D outcome data were available and the cohort investigators agreed to participate. We estimated incidence rate ratios (IRRs) and CIs of associations using individual participant data including ≤42,473 incident cases among 807,785 adults without diabetes in 27 cohorts across the Americas, Eastern Mediterranean, Europe, and Western Pacific. Random-effects meta-analysis was used to combine effect estimates and estimate heterogeneity. Median total legume intake ranged from 0-140 g/d across cohorts. We observed a weak positive association between total legume consumption and T2D (IRR = 1.02, 95% CI: 1.01 to 1.04) per 20 g/d higher intake, with moderately high heterogeneity (I2 = 74%). Analysis by region showed no evidence of associations in the Americas, Eastern Mediterranean, and Western Pacific. The positive association in Europe (IRR = 1.05, 95% CI: 1.01 to 1.10, I2 = 82%) was mainly driven by studies from Germany, UK, and Sweden. No evidence of associations was observed for the consumption of pulses or soy. These findings suggest no evidence of an association of legume intakes with T2D in several world regions. The positive association observed in some European studies warrants further investigation relating to overall dietary contexts in which legumes are consumed, including accompanying foods which may be positively associated with T2D.

Sections du résumé

BACKGROUND
The consumption of legumes is promoted as part of a healthy diet in many countries but associations of total and types of legume consumption with type 2 diabetes (T2D) are not well established. Analyses across diverse populations are lacking despite the availability of unpublished legume consumption data in prospective cohort studies.
OBJECTIVE
To examine the prospective associations of total and types of legume intake with the risk of incident T2D.
METHODS
Meta-analyses of associations between total legume, pulse, and soy consumption and T2D were conducted using a federated approach without physical data-pooling. Prospective cohorts were included if legume exposure and T2D outcome data were available and the cohort investigators agreed to participate. We estimated incidence rate ratios (IRRs) and CIs of associations using individual participant data including ≤42,473 incident cases among 807,785 adults without diabetes in 27 cohorts across the Americas, Eastern Mediterranean, Europe, and Western Pacific. Random-effects meta-analysis was used to combine effect estimates and estimate heterogeneity.
RESULTS
Median total legume intake ranged from 0-140 g/d across cohorts. We observed a weak positive association between total legume consumption and T2D (IRR = 1.02, 95% CI: 1.01 to 1.04) per 20 g/d higher intake, with moderately high heterogeneity (I2 = 74%). Analysis by region showed no evidence of associations in the Americas, Eastern Mediterranean, and Western Pacific. The positive association in Europe (IRR = 1.05, 95% CI: 1.01 to 1.10, I2 = 82%) was mainly driven by studies from Germany, UK, and Sweden. No evidence of associations was observed for the consumption of pulses or soy.
CONCLUSIONS
These findings suggest no evidence of an association of legume intakes with T2D in several world regions. The positive association observed in some European studies warrants further investigation relating to overall dietary contexts in which legumes are consumed, including accompanying foods which may be positively associated with T2D.

Identifiants

pubmed: 33693815
pii: S0022-3166(22)00157-2
doi: 10.1093/jn/nxaa447
pmc: PMC8112771
doi:

Substances chimiques

Soybean Proteins 0

Types de publication

Journal Article Meta-Analysis Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1231-1240

Subventions

Organisme : Medical Research Council
ID : MC_UU_00006/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 212946/Z/18/Z
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 29186
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12026/2
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00017/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_U137686851
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S011676/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00006/3
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12015/5
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12015/1
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C20/A5860
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R024227/1
Pays : United Kingdom

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the American Society for Nutrition.

Références

Ann Intern Med. 2002 Feb 5;136(3):201-9
pubmed: 11827496
BMJ. 2019 Jul 03;366:l2368
pubmed: 31270064
Diabetes Care. 2008 Dec;31(12):2281-3
pubmed: 18835944
Clin Nutr. 2018 Jun;37(3):906-913
pubmed: 28392166
Adv Nutr. 2010 Nov;1(1):17-30
pubmed: 22043448
Diabetologia. 2009 Aug;52(8):1479-95
pubmed: 19526214
Am J Clin Nutr. 2020 Mar 1;111(3):677-688
pubmed: 31915830
Eur J Epidemiol. 2017 May;32(5):363-375
pubmed: 28397016
Adv Nutr. 2019 Nov 1;10(Suppl_4):S308-S319
pubmed: 31728500
Eur J Clin Nutr. 2011 Feb;65(2):279-82
pubmed: 20924394
J Nutr. 2019 Jul 1;149(7):1208-1214
pubmed: 31079144
Lancet. 2015 Dec 5;386(10010):2287-323
pubmed: 26364544
Eur J Clin Nutr. 2016 Dec;70(12):1381-1387
pubmed: 27380886
Stat Med. 2012 Jun 15;31(13):1361-8
pubmed: 22415661
J Acad Nutr Diet. 2018 Jan;118(1):74-100.e11
pubmed: 29111090
Diabetes Care. 2008 Jul;31(7):1311-7
pubmed: 18390796
J Diabetes Investig. 2013 Nov 27;4(6):626-33
pubmed: 24843718
Diabetes Res Clin Pract. 2019 Nov;157:107843
pubmed: 31518657
J Nutr. 2010 Mar;140(3):580-6
pubmed: 20053935
Am J Clin Nutr. 2008 Jan;87(1):162-7
pubmed: 18175751
Lancet Glob Health. 2015 Mar;3(3):e132-42
pubmed: 25701991
Am J Epidemiol. 2007 Mar 15;165(6):603-10
pubmed: 17220476
Eur J Clin Nutr. 2013 Apr;67(4):412-9
pubmed: 23388667
Int J Epidemiol. 2014 Dec;43(6):1929-44
pubmed: 25261970
Stat Med. 1990 Oct;9(10):1157-65
pubmed: 2247716
Diabetes Care. 2004 Dec;27(12):2993-6
pubmed: 15562224
Diabetologia. 2005 Jun;48(6):1126-34
pubmed: 15889235
Lancet. 2019 Feb 2;393(10170):447-492
pubmed: 30660336
Diabetes Care. 2016 Nov;39(11):1987-1995
pubmed: 27493134
Am J Clin Nutr. 2000 Apr;71(4):921-30
pubmed: 10731498
J Natl Cancer Inst. 2000 Nov 1;92(21):1740-52
pubmed: 11058617
Diabetes Care. 2011 Sep;34(9):1913-8
pubmed: 21788627
Br J Nutr. 2013 Mar 28;109(6):1143-53
pubmed: 22850191
Eur J Nutr. 2012 Dec;51(8):1033-40
pubmed: 22094581

Auteurs

Matthew Pearce (M)

Medical Research Council Epidemiology Unit, University of Cambridge School of Clinical Medicine, CB2 0QQ, Cambridge, United Kingdom.

Anouar Fanidi (A)

Medical Research Council Epidemiology Unit, University of Cambridge School of Clinical Medicine, CB2 0QQ, Cambridge, United Kingdom.

Tom R P Bishop (TRP)

Medical Research Council Epidemiology Unit, University of Cambridge School of Clinical Medicine, CB2 0QQ, Cambridge, United Kingdom.

Stephen J Sharp (SJ)

Medical Research Council Epidemiology Unit, University of Cambridge School of Clinical Medicine, CB2 0QQ, Cambridge, United Kingdom.

Fumiaki Imamura (F)

Medical Research Council Epidemiology Unit, University of Cambridge School of Clinical Medicine, CB2 0QQ, Cambridge, United Kingdom.

Stefan Dietrich (S)

Department of Molecular Epidemiology, German Institute of Human Nutrition, Nuthetal, Germany.

Tasnime Akbaraly (T)

Inserm U 1198, Montpellier University, Montpellier, France.

Maira Bes-Rastrollo (M)

Departments of Preventive Medicine and Public Health, University of Navarra, Pamplona, Spain.
Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition, Instituto de Salud Carlos III, Madrid, Spain.
Navarra's Health Research Institute (IdiSNA), Pamplona, Spain.

Joline W J Beulens (JWJ)

Department of Epidemiology & Biostatistics and the Amsterdam Public Health Institute, Amsterdam University Medical Center, HV, Amsterdam, The Netherlands.

Liisa Byberg (L)

Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.

Scheine Canhada (S)

Faculty of Medicine, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.

Maria Del Carmen B Molina (MDCB)

Postgraduate Program in Nutrition and Health, Federal University of Espírito Santo, Vitória, Brazil.

Zhengming Chen (Z)

Medical Research Council Population Health Research Unit, University of Oxford, Oxford, United Kingdom.
Clinical Trial Service Unit and Epidemiological Studies Unit, University of Oxford, Oxford, United Kingdom.

Adrian Cortes-Valencia (A)

Center for Research on Population Health, National Institute of Public Health, Cuernavaca, Mexico.

Huaidong Du (H)

Medical Research Council Population Health Research Unit, University of Oxford, Oxford, United Kingdom.
Clinical Trial Service Unit and Epidemiological Studies Unit, University of Oxford, Oxford, United Kingdom.

Bruce B Duncan (BB)

Faculty of Medicine, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.

Tommi Härkänen (T)

Department of Public Health Solutions, Finnish Institute for Health and Welfare, Helsinki, Finland.

Maryam Hashemian (M)

Digestive Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Biology Department, School of Arts and Sciences, Utica College, Utica, USA.

Jihye Kim (J)

Department of Preventive Medicine, Hanyang University, Seoul, South Korea.

Mi Kyung Kim (MK)

Department of Preventive Medicine, Hanyang University, Seoul, South Korea.

Yeonjung Kim (Y)

National Research Institute of Health, Centers for Disease Control and Prevention, Cheongju, South Korea.

Paul Knekt (P)

Department of Public Health Solutions, Finnish Institute for Health and Welfare, Helsinki, Finland.

Daan Kromhout (D)

Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Camille Lassale (C)

Department of Epidemiology and Public Health, University College London, London, United Kingdom.
Cardiovascular Risk and Nutrition Group, Hospital del Mar Research Institute (IMIM), Barcelona, Spain.

Ruy Lopez Ridaura (RL)

Center for Research on Population Health, National Institute of Public Health, Cuernavaca, Mexico.

Dianna J Magliano (DJ)

Baker Heart and Diabetes Institute, Melbourne, Australia.

Reza Malekzadeh (R)

Digestive Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran.

Pedro Marques-Vidal (P)

Department of Medicine, Lausanne University Hospital, Lausanne, Switzerland.

Miguel Ángel Martínez-González (MÁ)

Departments of Preventive Medicine and Public Health, University of Navarra, Pamplona, Spain.
Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition, Instituto de Salud Carlos III, Madrid, Spain.
Navarra's Health Research Institute (IdiSNA), Pamplona, Spain.
Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Gráinne O'Donoghue (G)

School of Public Health, Physiotherapy & Sports Science, University College Dublin, Dublin, Ireland.

Donal O'Gorman (D)

School of Health & Human Performance, Dublin City University, Dublin, Ireland.

Jonathan E Shaw (JE)

Baker Heart and Diabetes Institute, Melbourne, Australia.

Sabita S Soedamah-Muthu (SS)

Center of Research on Psychological and Somatic Disorders (CoRPs), Tilburg University, Tilburg, The Netherlands.
Institute for Food, Nutrition and Health, University of Reading, Reading, United Kingdom.

Dalia Stern (D)

National Council of Science and Technology (CONACyT)-Center for Research on Population Health, National Institute of Public Health, Cuernavaca, Mexico.

Alicja Wolk (A)

Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

Hye Won Woo (HW)

Department of Preventive Medicine, Hanyang University, Seoul, South Korea.

Nicholas J Wareham (NJ)

Medical Research Council Epidemiology Unit, University of Cambridge School of Clinical Medicine, CB2 0QQ, Cambridge, United Kingdom.

Nita G Forouhi (NG)

Medical Research Council Epidemiology Unit, University of Cambridge School of Clinical Medicine, CB2 0QQ, Cambridge, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH